Novara, Italy

Roberto Baima

This inventor holds 1 USPTO granted patent. Top assignee: Galvanevet S.p.a.. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Roberto Baima

Introduction

Roberto Baima is a notable inventor based in Novara, Italy. He has made significant contributions to the field of chemistry, particularly through his innovative patent related to the synthesis of a specific compound. His work exemplifies the intersection of creativity and scientific inquiry.

Latest Patents

Roberto Baima holds a patent for a process that synthesizes 1-pyridiniumpropane-3-sulphonate. This compound is obtained by reacting 1-allylpyridinium chloride with alkaline bisulfite in an aqueous solution. The process involves the use of radical initiators, such as oxygen, hydrogen peroxide, peroxides, alkylhydroperoxides, and alkaline or ammonium persulfates. This patent highlights his expertise in chemical synthesis and innovation.

Career Highlights

Baima is associated with Galvanevet S.p.a., where he applies his knowledge and skills in a professional setting. His work at the company reflects his commitment to advancing chemical processes and contributing to the industry. His innovative approach has positioned him as a valuable asset in his field.

Collaborations

Roberto Baima collaborates with talented individuals such as Francesca Fontana and Anna Serri. These partnerships enhance his research and development efforts, fostering a collaborative environment that encourages innovation.

Conclusion

Roberto Baima's contributions to the field of chemistry through his patent and professional endeavors demonstrate his dedication to innovation. His work not only advances scientific knowledge but also showcases the importance of collaboration in achieving groundbreaking results.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…